The above details have been derived from the company’s sustainability report, and have been organized to provide both inputs and context.
The quote has been derived from an external media source. Should you have any comments or wish to point out any edits, please send a note to narsi@eai.in and we will do the needful. Thanks – Narasimhan, Director, EAI
For pharma companies, as it is for most companies, switching to solar power from coal power is almost plug and play.
What is more encouraging is their transition to biomass, a much more challenging feedstock, given that the supply chain for reliable biomass feedstock at scale is still evolving in the country.
Narsi, a Director at EAI, Co-founded one of India's first climate tech consulting firm in 2008.
Since then, he has assisted over 250 Indian and International firms, across many climate tech domain Solar, Bio-energy, Green hydrogen, E-Mobility, Green Chemicals.
Narsi works closely with senior and top management corporates and helps then devise strategy and go-to-market plans to benefit from the fast growing Indian Climate tech market.
Know More...Connect with our director
